CRON
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (March 30th, 2019)
SAFE Banking Act Passes First Step Bottom Line: The SAFE act would open up the banking system to cannabis companies…
Cronos Q4 2018 Earnings Review – The New Most Expensive Stock in Cannabis
In Cronos' (TSX: CRON) latest earnings report, they both grabbed the crown for most expensive cannabis company and disappointed with…
Tilray Q4 2018 Earnings – Eye Watering Stock Price Hard to Justify
Bottom Line This is likely a quarter Tilray's management wants to forget. Revenue of C$20.9 million missed even the low…
HEXO Q2 2019 Earnings – On the Edge of Profitability
A full review of HEXO (TSE: HEXO) Q2 2019 earnings. Should you buy this value priced name or are there…
Altria Invests $2.4 Billion in Cronos Group
In an effort to develop new product lines and expand large-scale cultivation capabilities, Cronos Group Inc. (NASDAQ: CRON; TSX: CRON) just…
Canopy Growth Q2 2019 Earnings Review – Big Growth With a Big Cost Structure to Match
Bottom Line: Investors will probably like this earnings release from Canopy Growth (TSE: WEED; NYSE: CGC). Net revenue of $83…
Aurora Cannabis Q2 2019 Earnings Review – Recreational Ramp Slower Than Expected
Bottom Line Aurora has arrived as a major player in the recreational market capturing ~20% market share of rec volumes…
Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (February 9th, 2019)
Be Cautious of Owning Pot Stocks into Earnings Next Week Bottom Line: Potential mark to market losses on investments in other…
Aphria Q2 2019 Earnings Review – Management Cloud Lifted, Assets Free to Shine
Bottom Line We firmly believe the decision by CEO Vic Neufeld to step aside is a big move in the…